A prospective, observational, descriptive study of Sputnik-V, AstraZeneca and Sinopharm SARS-CoV-2 vaccines in people living with HIV in Argentina
Latest Information Update: 19 Dec 2022
At a glance
- Drugs AZD 1222 (Primary) ; Coronavirus vaccine-Wuhan Institute of Biological Products (Primary) ; COVID-19 vaccine-Gamaleya National Research Center of Epidemiology and Microbiology (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 26 Oct 2022 Results(n=100) assessing Immunogenicity of homologous versus heterologous prime-boost vaccination regimens against SARS-COV-2 in people living with HIV in Argentina presented at the 16th International Congress on Drug Therapy and HIV Infection
- 08 Sep 2022 New trial record
- 02 Aug 2022 Results presented at the 24th International AIDS Conference